Change the keyword or sentiment above, then click Apply.
Friday, 18 Sep 20261 update
↗ AI sentiment: Bullish
95% confidence
Laurus Labs Q1 Revenue Surges 29%, EBITDA Up 66%
Laurus Labs posted strong Q1 FY27 results with ₹2,026 Cr revenue, 29% growth, driven by CDMO and Affordable Medicines segments.
EBITDA rose 66% Y/Y to ₹644 Cr, margins at 31.8%; gross margins expanded by 3.3% pts to 62.7% on better segment mix.
Source: BSE
Wednesday, 16 Sep 20261 update
↔ AI sentiment: Neutral
53% confidence
Laurus Labs Sees ₹80.6 Cr Block Deal on NSE at ₹1,874.6/Share
Laurus Labs saw an NSE block trade worth Rs. 80.6 crore for ~430,164 shares.
The trade was executed at Rs. 1,874.6 per share.
Source: Livesquawk
Tuesday, 15 Sep 20261 update
↔ AI sentiment: Neutral
92% confidence
Laurus Labs: To Meet With Analysts And Investors On September 22
Monday, 31 Aug 20267 updates
↔ AI sentiment: Neutral
90% confidence
Societe Generale Sells ₹535 Cr Laurus Labs Shares at ₹1903.84 Each
SOCIETE GENERALE sold 2,810,437 Laurus Labs shares at ₹1903.84/share.
Total transaction value amounted to ₹535.1 crores on 2026-08-31.
Source: ScoutQuest
CAS triggered a 600-point rise in Nifty Bank, closing above 58,000; turnover hit ₹39,717 cr.
ICICI Bank, Axis Bank, SBI, Federal Bank saw notable price changes; MSCI rebalancing impacted stocks like Eternal, Laurus Labs.
Source: CNBC TV 18
↔ AI sentiment: Neutral
92% confidence
Laurus Labs to Meet Investors on Sept 7: Key Updates Expected
Laurus Labs to meet analysts and investors on Sept 7.
Meeting signals potential updates or communication with the Street.
Source: Livesquawk
↔ AI sentiment: Neutral
90% confidence
Laurus Labs: Company To Host Meeting With Analysts And Investors On September 7